Buprenorphine vs Ipilimumab
Buprenorphine vs Ipilimumab: Overview
This comparison examines the pharmacological differences between Buprenorphine and Ipilimumab.
Mechanism of Action
Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Buprenorphine — 24-42 hours; Ipilimumab — 14.7 days.
Chemical Properties
Molecular Formula: Buprenorphine — C29H41NO4.
Molecular Weight: Buprenorphine — 467.6430 g/mol.
Type: Buprenorphine — Small molecule; Ipilimumab — Antibody.